Albert David Ltd

Albert David Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Albert David Ltd

₹
- close price
albertdavidindia.com BSE: 524075 NSE: ALBERTDAVD
About

Incorporated in 1938, Albert David
Ltd is in the business of manufacturing pharmaceutical products[1]

Key Points

Business Overview:[1]
ADL is a part of the Kolkata-based Kothari Group. It is a prominent drug house, which is in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs, etc. Company is in strategic liaison with academic institutes like the Indian Institute of Chemical Biology (CSIR) & Department of Biotechnology, Calcutta University for outsourcing research.

Website BSE NSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Figures in Rs. Crores

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Revenue from Large Volume Parenterals
₹ Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Revenue from Syrups/Liquids
₹ Lakhs ・Standalone data
Total Number of Permanent Employees
Number ・Standalone data
Number of Stockists
Number ・Standalone data
Contribution of Top Product (Placentrex)
% ・Standalone data
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
62.04% 62.04% 62.04% 62.13% 62.13% 62.13% 62.13% 62.23% 62.23% 62.23% 62.23% 62.23%
0.65% 0.57% 0.70% 0.98% 0.80% 0.88% 0.86% 1.00% 0.84% 0.60% 0.60% 0.58%
2.30% 1.90% 1.67% 1.67% 1.67% 1.63% 1.63% 1.64% 1.65% 1.65% 1.65% 1.65%
35.01% 35.49% 35.60% 35.23% 35.41% 35.36% 35.39% 35.12% 35.27% 35.50% 35.51% 35.52%
No. of Shareholders 9,8289,90710,04111,26612,34913,59014,83015,30415,07014,66613,96713,555

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings